Cargando…

Azithromycin/dexamethasone/voriconazole: Pulmonary aspergillosis following off-label use, and lack of efficacy: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997546/ http://dx.doi.org/10.1007/s40278-021-93086-8

Ejemplares similares

Dexamethasone/voriconazole: Invasive aspergillosis following off-label use; lack of efficacy: case report
Publicado: (2022)

Convalescent-anti-SARS-CoV-2-plasma/dexamethasone/voriconazole: Invasive pulmonary aspergillosis, off label use and lack of efficacy: case report
Publicado: (2021)

Azithromycin/dexamethasone/methylprednisolone: Aspergillosis, mucormycosis and off-label use: case report
Publicado: (2022)

Dexamethasone: Invasive pulmonary aspergillosis following off-label use: case report
Publicado: (2021)

Azithromycin: Lack of efficacy and off-label use: case report
Publicado: (2021)

Voriconazole: Lack of efficacy during treatment of invasive pulmonary aspergillosis: 2 case reports
Publicado: (2021)

Dexamethasone: Lack of efficacy following off-label use: case report
Publicado: (2022)

Dexamethasone: Pulmonary mucormycosis, pulmonary aspergillosis and off-label use: case report
Publicado: (2021)

Dexamethasone/tocilizumab: Lack of efficacy following off-label therapy: case report
Publicado: (2022)

Dexamethasone: Chronic cavitary pulmonary aspergillosis and off label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Azithromycin/favipiravir/hydroxychloroquine: Lack of efficacy and off-label use: case report
Publicado: (2021)

Azithromycin/inosine-pranobex off label use: Lack of efficacy: case report
Publicado: (2022)

Dexamethasone/piperacillin/tazobactam: Lack of efficacy following off-label use: case report
Publicado: (2021)

Aciclovir/dexamethasone/remdesivir: Lack of efficacy following off-label use: case report
Publicado: (2022)

Ceftriaxone/dexamethasone/levofloxacin: Lack of efficacy following off-label use: case report
Publicado: (2022)

Dexamethasone/voriconazole: Invasive pulmonary aspergillosis secondary to Aspergillus terreus and treatment failure: case report
Publicado: (2021)

Azithromycin/ceftriaxone/remdesivir: Bradycardia and lack of efficacy following off-label use: 2 case reports
Publicado: (2022)

Norepinephrine/oseltamivir: Lack of efficacy and invasive pulmonary aspergillosis secondary to off-label use: case report
Publicado: (2020)

Multiple drugs: Invasive pulmonary aspergillosis, lack of efficacy and off-label therapy: 4 case reports
Publicado: (2020)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off label use: case report
Publicado: (2021)

Dexamethasone/methylprednisolone: Off label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/tocilizumab: Off-label-use and lack of efficacy: case report
Publicado: (2021)

Azithromycin/dexamethasone/prednisone: Lack of efficacy, off label use and rebound effect in the form of worsening of subacute thyroiditis: 3 case reports
Publicado: (2022)

Dexamethasone/tocilizumab/tofacitinib: Lack of efficacy following off label use: 2 case reports
Publicado: (2022)

Dexamethasone/enoxaparin-sodium/remdesivir: Lack of efficacy following off-label use: case report
Publicado: (2021)

Azd-1222/dexamethasone: Lack of efficacy and hyperglycaemia following off label use: case report
Publicado: (2022)

Dexamethasone/tocilizumab: Lack of efficacy during off label use: case report
Publicado: (2022)

Apixaban/dexamethasone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/meropenem: Infections, off label use and lack of efficacy: case report
Publicado: (2022)

Ciprofloxacin/corticosteroids/dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy and off label use: case report
Publicado: (2021)

Antibacterials/corticosteroids/dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Off-label use and lack of efficacy: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vsqgum87i8em4cobvkv8kgbkmg